Metalyse and ventricular fibrillation Patient Reports February 09, 2010

Metalyse Side Effects Report #5063678-8
Metalyse side effect was reported by a Physician from GREECE on July 21, 2006. Male patient, 51 years of age, was diagnosed with myocardial infarction and was treated with Metalyse. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure, cardiogenic shock, respiratory tract infection, ventricular fibrillation. Metalyse dosage: unknown. During the same period patient was treated with ASPIRIN, MORPHINE, HEPARIN, CLOPIDOGREL, NITRATES, DIURETICS. Patient was hospitalized. Patient died on 01/20/2006.

Metalyse Side Effects Report #5024936-6
Metalyse side effect was reported by a Physician from GERMANY on May 24, 2006. Male patient, 51 years of age, was diagnosed with myocardial infarction and was treated with Metalyse. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure, cardiogenic shock, respiratory tract infection, ventricular fibrillation. Metalyse dosage: unknown. During the same period patient was treated with ASPIRIN, MORPHINE, HEPARIN, CLOPIDOGREL, NITRATES, DIURETICS. Patient was hospitalized. Patient died on 01/20/2006.

Metalyse Side Effects Report #6051879-1
Metalyse side effect was reported by a Physician from NEW ZEALAND on Jan 20, 2009. Male patient, weighting 176.4 lb, was diagnosed with myocardial infarction, cardiogenic shock and was treated with Metalyse. After drug was administered, patient experienced the following side effects: cardiac arrest , ventricular fibrillation. Metalyse dosage: 40 MG, UNK. Patient died on 12/01/2007.

Metalyse Side Effects Report #4900798-X
Metalyse side effect was reported by a Health Professional from GREECE on Jan 17, 2006. Male patient, 80 years of age, was diagnosed with acute myocardial infarction and was treated with Metalyse. After drug was administered, patient experienced the following side effects: angina pectoris, cardiogenic shock, disease recurrence, ventricular fibrillation. Metalyse dosage: 50 MG, SINGLE, INTRAVENOUS. During the same period patient was treated with ANTICOAGULANTS, NITRATES NOS, CALCIUM ANTAGONISTS, HYPOLIPIDEMICS, ASPIRIN, HEPARIN. Patient died on 08/13/2005.


Metalyse Side Effects Report #5024202-9
Metalyse side effect was reported by a Health Professional from GERMANY on June 03, 2006. Male patient, 80 years of age, was diagnosed with acute myocardial infarction and was treated with Metalyse. After drug was administered, patient experienced the following side effects: angina pectoris, cardiogenic shock, disease recurrence, ventricular fibrillation. Metalyse dosage: 50 MG, SINGLE, INTRAVENOUS. During the same period patient was treated with ANTICOAGULANTS, NITRATES NOS, CALCIUM ANTAGONISTS, HYPOLIPIDEMICS, ASPIRIN, HEPARIN. Patient died on 08/13/2005.

Metalyse Side Effects Report #4985991-2
Metalyse side effect was reported by a Physician from GREECE on Apr 10, 2006. Female patient, 60 years of age, was diagnosed with acute myocardial infarction and was treated with Metalyse. After drug was administered, patient experienced the following side effects: cardiogenic shock, ventricular fibrillation. Metalyse dosage: unknown. During the same period patient was treated with ASPIRIN, HEPARIN, CLOPIDOGREL, TICLODONE, BETA BLOCKERS, NITRATES NOS, STATINS NOS, INOTROPIC AGENT. Patient recovered.

Metalyse Side Effects Report #5024249-2
Metalyse side effect was reported by a Consumer or non-health professional from GREECE on June 03, 2006. Female patient, 60 years of age, was diagnosed with acute myocardial infarction and was treated with Metalyse. After drug was administered, patient experienced the following side effects: cardiogenic shock, ventricular fibrillation. Metalyse dosage: unknown. During the same period patient was treated with ASPIRIN, HEPARIN, CLOPIDOGREL, TICLODONE, BETA BLOCKERS, NITRATES NOS, STATINS NOS, INOTROPIC AGENT. Patient recovered.

Metalyse Side Effects Report #4960298-8
Metalyse side effect was reported by a Consumer or non-health professional from GERMANY on Mar 15, 2006. Male patient, 38 years of age, was diagnosed with acute myocardial infarction and was treated with Metalyse. After drug was administered, patient experienced the following side effects: cardiogenic shock, ventricular fibrillation. Metalyse dosage: unknown. During the same period patient was treated with ANTICOAGULANT, BETA BLOCKERS, HYPOLIPIDEMICS, INOTROPIC AGENT. Patient was hospitalized. Patient recovered.

Metalyse Side Effects Report #5024251-0
Metalyse side effect was reported by a Health Professional from GREECE on June 03, 2006. Male patient, 38 years of age, was diagnosed with acute myocardial infarction and was treated with Metalyse. After drug was administered, patient experienced the following side effects: cardiogenic shock, ventricular fibrillation. Metalyse dosage: unknown. During the same period patient was treated with ANTICOAGULANT, BETA BLOCKERS, HYPOLIPIDEMICS, INOTROPIC AGENT. Patient was hospitalized. Patient recovered.